Meddling with Fate: The Proteasomal Deubiquitinating Enzymes

被引:95
|
作者
de Poot, Stefanie A. H. [1 ]
Tian, Geng [1 ]
Finley, Daniel [1 ]
机构
[1] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
deubiquitinating enzymes; proteasome; Rpn11; Usp14; Uch37; UBIQUITINATED PROTEINS ACTIVATE; SMALL-MOLECULE INHIBITOR; TERMINAL HYDROLASE 37; 26S PROTEASOME; PROVIDES INSIGHTS; DEUBIQUITYLATING ENZYMES; SUBSTRATE-SPECIFICITY; DEGRADATION SIGNAL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS;
D O I
10.1016/j.jmb.2017.09.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three deubiquitinating enzymes-Rpnl 1, Usp14, and Uch37-are associated with the proteasome regulatory particle. These enzymes allow proteasomes to remove ubiquitin from substrates before they are translocated into the core particle to be degraded. Although the translocation channel is too narrow for folded proteins, the force of translocation unfolds them mechanically. As translocation proceeds, ubiquitin chains bound to substrate are drawn to the channel's entry port, where they can impede further translocation. Rpn11, situated over the port, can remove these chains without compromising degradation because substrates must be irreversibly committed to degradation before Rpn11 acts. This coupling between deubiquitination and substrate degradation is ensured by the Ins-1 loop of Rpnl 1, which controls ubiquitin access to its catalytic site. In contrast to Rpnl 1, Usp14 and Uch37 can rescue substrates from degradation by promoting substrate dissociation from the proteasome prior to the commitment step. Uch37 is unique in being a component of both the proteasome and a second multisubunit assembly, the IN080 complex. However, only recruitment into the proteasome activates Uch37. Recruitment to the proteasome likewise activates Usp14. However, the influence of Usp14 on the proteasome depends on the substrate, due to its marked preference for proteins that carry multiple ubiquitin chains. Usp14 exerts complex control over the proteasome, suppressing proteasome activity even when inactive in deubiquitination. A major challenge for the field will be to elucidate the specificities of Rpn11, Usp14, and Uch37 in greater depth, employing not only model in vitro substrates but also their endogenous targets. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3525 / 3545
页数:21
相关论文
共 50 条
  • [21] Deubiquitinating enzymes: Their diversity and emerging roles
    Chung, CH
    Baek, SH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (03) : 633 - 640
  • [22] Structure and Function of Viral Deubiquitinating Enzymes
    Bailey-Elkin, Ben A.
    Knaap, Robert C. M.
    Kikkert, Marjolein
    Mark, Brian L.
    JOURNAL OF MOLECULAR BIOLOGY, 2017, 429 (22) : 3441 - 3470
  • [23] Deubiquitinating enzymes are IN(trinsic to proteasome function)
    Guterman, A
    Glickman, MH
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2004, 5 (03) : 201 - 211
  • [24] Deubiquitinating enzymes: Their functions and substrate specificity
    Soboleva, TA
    Baker, RT
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2004, 5 (03) : 191 - 200
  • [25] Regulation of proteolysis by human deubiquitinating enzymes
    Eletr, Ziad M.
    Wilkinson, Keith D.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2014, 1843 (01): : 114 - 128
  • [26] Deubiquitinating Enzymes in Parkinson's Disease
    Chakraborty, Joy
    Ziviani, Elena
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [27] Deubiquitinating enzymes for targeted cancer therapy
    Li, Yue
    Wang, Xiaohui
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2023, 3 (06):
  • [28] The role of deubiquitinating enzymes in chromatin regulation
    Atanassov, Boyko S.
    Koutelou, Evangelia
    Dent, Sharon Y.
    FEBS LETTERS, 2011, 585 (13) : 2016 - 2023
  • [29] Role of Deubiquitinating Enzymes in DNA Repair
    Kee, Younghoon
    Huang, Tony T.
    MOLECULAR AND CELLULAR BIOLOGY, 2016, 36 (04) : 524 - 544
  • [30] Inhibiting the Deubiquitinating Enzymes (DUBs) Miniperspective
    Ndubaku, Chudi
    Tsui, Vickie
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (04) : 1581 - 1595